Survival With Patients Treated With Salivary Gland Cancer

Clinical Center of Vojvodina250 enrolled

Overview

Salivary gland malignancies is very heterogenous group of tumors regarding tumor histology and localization. The aim of this study is to assess main clinical and pathological parameters related to patients survival

The retrospective study enrolled medical charts of the patients treated due to salivaly gland cancers in the Clinic for maxillofacial surgery at Clinical center of Vojvodina in the period of 1. January 1996. to 31. December 2021. Patients demographics, type of the tumor, localization, TNM status and patohystological parameters were evaluated for patients survival and disease free periods

Study Type

OBSERVATIONAL

Enrollment

250

Conditions

Salivary Gland Cancer Salivary Gland Neoplasms

Interventions

Surgical intervention with or without postoperative adjuvant therapyPROCEDURE

Surgical intervention with or without postoperative adjuvant therapy

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: Patients with salivary gland malignancies treted in the Clinic for maxillofacial surgery Exclusion Criteria: Incomplete medical data Patients with metastatic tumord of salivary gland Patients with recurrent malignancies of salivary glands sent from other clinics

Locations (1)

Clinic for maxillofacial surgery Clinical center of Vojvodina

Novi Sad, Serbia

Outcomes

Primary Outcomes

Patients survival

Survival of patients treated due to SGC during observation period of minimum 2 years

Time frame: Through study completion, an average of 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.